Bruker Corp (BRKR)
93.94
+0.08
(+0.09%)
USD |
NASDAQ |
Mar 28, 16:00
93.86
-0.08
(-0.09%)
After-Hours: 20:00
Bruker Cash from Financing (TTM): -193.40M for Dec. 31, 2023
Cash from Financing (TTM) Chart
Historical Cash from Financing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | -193.40M |
September 30, 2023 | -169.60M |
June 30, 2023 | -159.10M |
March 31, 2023 | -228.60M |
December 31, 2022 | -415.30M |
September 30, 2022 | 25.10M |
June 30, 2022 | 104.50M |
March 31, 2022 | 139.40M |
December 31, 2021 | 318.70M |
September 30, 2021 | -159.90M |
June 30, 2021 | -382.80M |
March 31, 2021 | -391.00M |
December 31, 2020 | -161.60M |
September 30, 2020 | 190.60M |
June 30, 2020 | 396.60M |
March 31, 2020 | 500.10M |
December 31, 2019 | 300.00M |
September 30, 2019 | 98.70M |
June 30, 2019 | 132.80M |
March 31, 2019 | 77.60M |
December 31, 2018 | -112.40M |
September 30, 2018 | -278.50M |
June 30, 2018 | -332.00M |
March 31, 2018 | -325.50M |
December 31, 2017 | -159.00M |
Date | Value |
---|---|
September 30, 2017 | -43.40M |
June 30, 2017 | -15.00M |
March 31, 2017 | -18.70M |
December 31, 2016 | -27.90M |
September 30, 2016 | -222.20M |
June 30, 2016 | -211.80M |
March 31, 2016 | -215.00M |
December 31, 2015 | -169.40M |
September 30, 2015 | -0.70M |
June 30, 2015 | 2.40M |
March 31, 2015 | 8.30M |
December 31, 2014 | 6.70M |
September 30, 2014 | 7.90M |
June 30, 2014 | 27.00M |
March 31, 2014 | 28.70M |
December 31, 2013 | 26.50M |
September 30, 2013 | 26.00M |
June 30, 2013 | 19.60M |
March 31, 2013 | 19.90M |
December 31, 2012 | 34.40M |
September 30, 2012 | 26.00M |
June 30, 2012 | 34.80M |
March 31, 2012 | 22.20M |
December 31, 2011 | 3.30M |
September 30, 2011 | 193.30M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (TTM) Range, Past 5 Years
-415.30M
Minimum
Dec 2022
500.10M
Maximum
Mar 2020
1.14M
Average
51.35M
Median
Cash from Financing (TTM) Benchmarks
Azenta Inc | -452.51M |
Harvard Bioscience Inc | -12.13M |
Bionano Genomics Inc | 113.82M |
Akoya Biosciences Inc | 56.84M |
Singular Genomics Systems Inc | 0.696M |